Castleman disease (CD) describes a group of at least 4 disorders that share a spectrum of
characteristic histopathological features but have a wide range of etiologies, presentations …

Castleman disease (CD) describes a group of heterogeneous hematologic disorders with
characteristic histopathological features. CD can present with unicentric or multicentric …

A subset of patients with severe COVID-19 develop profound inflammation and multi-organ
dysfunction consistent with a “Cytokine Storm Syndrome”(CSS). In this review we compare …

Castleman disease (CD) includes a group of rare and heterogeneous disorders with
characteristic lymph node histopathological abnormalities. CD can occur in a single lymph …

The spectrum of Castleman disease (CD) has considerably extended since its first
description in 1956. Recently, an international collaborative working group has reached …

Castleman disease (CD) describes a heterogeneous group of hematologic disorders that
share characteristic lymph node histopathology. Patients of all ages present with either a …

The term Castleman disease has been applied to several different lymphoproliferatiive
disorders comprising of several distinct clinicopathologic entities. 1–4 Its prevalence has …

Although Castleman disease was first described in 1956, this disease includes various
conditions, including unicentric Castleman disease with hyaline vascular histology, human …

Background Castleman disease (CD) is a group of rare and heterogenous
lymphoproliferative disorders including unicentric CD (UCD), human herpesvirus-8 (HHV-8) …

Idiopathic multicentric Castleman disease (iMCD) is subclassified into iMCD‐
thrombocytopenia, anasarca, reticulin fibrosis, renal dysfunction, organomegaly (TAFRO) …